Eddit
Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
− | + | {{tp|p=32352364|t=2020. Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base |pdf=|usr=}} | |
− | + | {{tp|p=32102777|t=2020. The 2019 novel coronavirus resource |pdf=|usr=}} ''https://bigd.big.ac.cn/ncov'' | |
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
Zeile 9: | Zeile 9: | ||
{{tp|p=32083985|t=2020. Coronavirus Disease 2019 (COVID-19): A Perspective from China |pdf=|usr=}} | {{tp|p=32083985|t=2020. Coronavirus Disease 2019 (COVID-19): A Perspective from China |pdf=|usr=}} | ||
{{tp|p=32301692|t=2020. What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32301692|t=2020. What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32220177|t=2020. Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review |pdf=|usr=}} | ||
+ | {{tp|p=32306500|t=2020. Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32064795|t=2020. Diagnosis and treatment recommendation for pediatric coronavirus disease-19 |pdf=|usr=}} | ||
+ | {{tp|p=32096367|t=2020. Management of corona virus disease-19 (COVID-19): the Zhejiang experience |pdf=|usr=}} | ||
+ | {{tp|p=32238232|t=2020. From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment |pdf=|usr=}} | ||
+ | {{tp|p=32186172|t=2020. Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
Zeile 15: | Zeile 23: | ||
{{tp|p=32159735|t=2020. Care for Critically Ill Patients With COVID-19 |pdf=|usr=}} | {{tp|p=32159735|t=2020. Care for Critically Ill Patients With COVID-19 |pdf=|usr=}} | ||
{{tp|p=32242438|t=2020. Primary care management of the coronavirus (COVID-19) |pdf=|usr=}} | {{tp|p=32242438|t=2020. Primary care management of the coronavirus (COVID-19) |pdf=|usr=}} | ||
− | + | {{tp|p=32220179|t=2020. The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19 |pdf=|usr=}} | |
− | + | {{tp|p=32352365|t=2020. Evidence Based Treatment of SARS-CoV2: A Narrative Review |pdf=|usr=}} | |
+ | {{tp|p=32135584|t=2020. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition) |pdf=|usr=}} | ||
+ | {{tp|p=32125126|t=2020. Management and clinical thinking of Coronavirus Disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32306656|t=2020. Clinical consideration and management of coronavirus disease 2019 |pdf=|usr=}} | ||
{{tp|p=32369222|t=2020. The management of coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32369222|t=2020. The management of coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | ||
Zeile 25: | Zeile 36: | ||
{{tp|p=32329799|t=2020. Management of COVID-19 Respiratory Distress |pdf=|usr=}} | {{tp|p=32329799|t=2020. Management of COVID-19 Respiratory Distress |pdf=|usr=}} | ||
{{tp|p=32376612|t=2020. Shared Ventilation in the Era of COVID-19: A Theoretical Consideration of the Dangers and Potential Solutions |pdf=|usr=}} | {{tp|p=32376612|t=2020. Shared Ventilation in the Era of COVID-19: A Theoretical Consideration of the Dangers and Potential Solutions |pdf=|usr=}} | ||
+ | {{tp|p=32268019|t=2020. Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients |pdf=|usr=}} | ||
+ | {{tp|p=32273335|t=2020. COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life |pdf=|usr=}} | ||
+ | {{tp|p=32100976|t=2020. Airway management of COVID-19 patients with severe pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32306624|t=2020. Airway management of COVID-19 patients with severe pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32259916|t=2020. Experience of tracheotomy for critical patients with COVID-19: a case report |pdf=|usr=}} | ||
+ | {{tp|p=32292012|t=2020. Application of tracheotomy in the treatment of severe cases of COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
Zeile 73: | Zeile 93: | ||
{{tp|p=32374545|t=2020. Utilite du CT-scan thoracique pour le diagnostic et le triage des patients suspects de COVID-19 |pdf=|usr=}} | {{tp|p=32374545|t=2020. Utilite du CT-scan thoracique pour le diagnostic et le triage des patients suspects de COVID-19 |pdf=|usr=}} | ||
{{tp|p=32351103|t=2020. The usual course of Thorax CT findings of Covid-19 infection and When should control Thorax CT scan?|pdf=|usr=}} | {{tp|p=32351103|t=2020. The usual course of Thorax CT findings of Covid-19 infection and When should control Thorax CT scan?|pdf=|usr=}} | ||
− | + | {{tp|p=32317269|t=2020. Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT |pdf=|usr=}} | |
− | + | {{tp|p=32352366|t=2020. How to Deal with COVID-19 Pandemic: A Radiologic Approach |pdf=|usr=}} | |
+ | {{tp|p=32286216|t=2020. Diagnostic imaging findings in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32294796|t=2020. Nicht-invasive Beurteilung von pulmonalen Lasionen bei Patienten mit Coronavirus-Erkrankung (COVID-19) durch Ultraschall direkt am Krankenbett |pdf=|usr=}} | ||
+ | {{tp|p=32294795|t=2020. ... Ultraschall in der Ara der COVID-19-Pandemie ... |pdf=|usr=}} | ||
+ | {{tp|p=32207208|t=2020. How to perform lung ultrasound in pregnant women with suspected COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32337795|t=2020. Clinical role of lung ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in pregnant women |pdf=|usr=}} | ||
+ | {{tp|p=32249471|t=2020. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32207591|t=2020. CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32096366|t=2020. Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32061200|t=2020. Analysis of CT features of 15 Children with 2019 novel coronavirus infection |pdf=|usr=}} | ||
+ | {{tp|p=32234131|t=2020. Analysis of CT features of 15 children with 2019 novel coronavirus infection |pdf=|usr=}} | ||
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
Zeile 95: | Zeile 125: | ||
{{tp|p=32225175|t=2020. Structural basis of receptor recognition by SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32225175|t=2020. Structural basis of receptor recognition by SARS-CoV-2 |pdf=|usr=}} | ||
{{ttp|p=32376634|t=2020. Cell entry mechanisms of SARS-CoV-2 |pdf=|usr=}} | {{ttp|p=32376634|t=2020. Cell entry mechanisms of SARS-CoV-2 |pdf=|usr=}} | ||
− | + | {{tp|p=32329276|t=2020. Spike protein in the detection and treatment of novel coronavirus |pdf=|usr=}} | |
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
+ | {{tp|p=32298055|t=2020. Replication and transmission mechanisms of highly pathogenic human coronaviruses |pdf=|usr=}} | ||
+ | |||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
Zeile 113: | Zeile 145: | ||
{{tp|p=32379199|t=2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes |pdf=|usr=}} | {{tp|p=32379199|t=2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes |pdf=|usr=}} | ||
{{tp|p=32267987|t=2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS |pdf=|usr=}} | {{tp|p=32267987|t=2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS |pdf=|usr=}} | ||
+ | {{tp|p=32296069|t=2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study |pdf=|usr=}} | ||
+ | {{ttp|p=32236983|t=2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |pdf=|usr=}} | ||
+ | {{tp|p=32348715|t=2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32297828|t=2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
Zeile 126: | Zeile 165: | ||
{{tp|p=32273618|t=2020. How does COVID-19 kill? Uncertainty is hampering doctors ability to choose treatments |pdf=|usr=}} | {{tp|p=32273618|t=2020. How does COVID-19 kill? Uncertainty is hampering doctors ability to choose treatments |pdf=|usr=}} | ||
{{ttp|p=32371892|t=2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms |pdf=|usr=}} | {{ttp|p=32371892|t=2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms |pdf=|usr=}} | ||
+ | {{tp|p=32339089|t=2020. Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis |pdf=|usr=}} | ||
+ | {{tp|p=32172546|t=2020. A pathological report of three COVID-19 cases by minimal invasive autopsies |pdf=|usr=}} | ||
+ | {{tp|p=32171194|t=2020. Pathological changes with novel coronavirus infection in lung cancer surgical specimen |pdf=|usr=}} | ||
+ | {{tp|p=32153166|t=2020. Provisional guidelines on autopsy practice for deaths associated with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32268662|t=2020. Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy |pdf=|usr=}} | ||
+ | {{tp|p=32157847|t=2020. How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32084674|t=2020. Detection of 2019-nCoV in the pathological paraffin embedded tissue |pdf=|usr=}} | ||
+ | {{tp|p=32340089|t=2020. Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies |pdf=|usr=}} | ||
+ | {{tp|p=32114744|t=2020. Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
{{tp|p=32380511|t=2020. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice |pdf=|usr=}} | {{tp|p=32380511|t=2020. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice |pdf=|usr=}} | ||
+ | {{tp|p=32369435|t=2020. Canine Respiratory Coronavirus: A Naturally Occurring Model of COVID-19?|pdf=|usr=}} | ||
+ | |||
+ | |||
Zeile 138: | Zeile 192: | ||
{{tp|p=32287052|t=2020. Febrile Infant: COVID-19 in Addition to the Usual Suspects |pdf=|usr=}} | {{tp|p=32287052|t=2020. Febrile Infant: COVID-19 in Addition to the Usual Suspects |pdf=|usr=}} | ||
{{ttp|p=32245885|t=2020. Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?|pdf=|usr=}} | {{ttp|p=32245885|t=2020. Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2?|pdf=|usr=}} | ||
+ | {{tp|p=32358120|t=2020. How related is SARS-CoV-2 to other coronaviruses?|pdf=|usr=}} | ||
+ | {{tp|p=15631713|t=2004. A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children |pdf=|usr=}} | ||
+ | {{tp|p=32198915|t=2020. When COVID-19 encounters interstitial lung disease: challenges and management |pdf=|usr=}} | ||
+ | |||
Zeile 162: | Zeile 220: | ||
{{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}} | {{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}} | ||
{{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}} | {{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}} | ||
+ | {{tp|p=32279286|t=2020. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring |pdf=|usr=}} | ||
+ | {{tp|p=32349133|t=2020. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge |pdf=|usr=}} | ||
+ | {{tp|p=32349132|t=2020. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?|pdf=|usr=}} | ||
+ | {{tp|p=32316065|t=2020. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines |pdf=|usr=}} | ||
+ | {{tp|p=32316063|t=2020. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure |pdf=|usr=}} | ||
+ | {{tp|p=32374920|t=2020. Viscoelastic testing in COVID-19: a possible screening tool for severe disease?|pdf=|usr=}} | ||
Zeile 192: | Zeile 256: | ||
{{tp|p=32240279|t=2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?|pdf=|usr=}} | {{tp|p=32240279|t=2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?|pdf=|usr=}} | ||
{{tp|p=32277751|t=2020. Presentation of new onset anosmia during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32277751|t=2020. Presentation of new onset anosmia during the COVID-19 pandemic |pdf=|usr=}} | ||
− | + | {{tp|p=32320129|t=2020. Explanation for COVID-19 infection neurological damage and reactivations |pdf=|usr=}} | |
− | + | {{tp|p=32220634|t=2020. Sars-Cov-2: Underestimated damage to nervous system |pdf=|usr=}} | |
Zeile 208: | Zeile 272: | ||
{{tp|p=32367837|t=2020. Gastrointestinal and liver manifestations of COVID-19 |pdf=|usr=}} | {{tp|p=32367837|t=2020. Gastrointestinal and liver manifestations of COVID-19 |pdf=|usr=}} | ||
{{tp|p=32369476|t=2020. Sintomas digestivos en la enfermedad por coronavirus 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32369476|t=2020. Sintomas digestivos en la enfermedad por coronavirus 2019 (COVID-19) |pdf=|usr=}} | ||
− | + | {{tp|p=32153170|t=2020. Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region |pdf=|usr=}} | |
− | + | {{tp|p=32270660|t=2020. Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area |pdf=|usr=}} | |
− | + | {{tp|p=32077660|t=2020. Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study |pdf=|usr=}} | |
− | + | {{tp|p=32077659|t=2020. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia |pdf=|usr=}} | |
− | + | {{tp|p=32075364|t=2020. Novel coronavirus pneumonia-related liver injury: etiological analysis and treatment strategy |pdf=|usr=}} | |
Zeile 256: | Zeile 320: | ||
{{tp|p=32160345|t=ä. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals |pdf=|usr=}} | {{tp|p=32160345|t=ä. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals |pdf=|usr=}} | ||
{{tp|p=32302282|t=2020. Sex- and Gender-specific Observations and Implications for COVID-19 |pdf=|usr=}} | {{tp|p=32302282|t=2020. Sex- and Gender-specific Observations and Implications for COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32364677|t=2020. COVID-19 pneumonia in kidney transplant recipients-Where we are?|pdf=|usr=}} | ||
+ | {{tp|p=32279418|t=2020. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32357273|t=2020. A catabolic state in a kidney transplant recipient with COVID-19 |pdf=|usr=}} | ||
+ | {{ttp|p=32180292|t=2020. Coronavirus in pregnancy and delivery: rapid review |pdf=|usr=}} | ||
+ | {{tp|p=32266753|t=2020. Intrauterine vertical transmission of SARS-CoV-2: what we know so far |pdf=|usr=}} | ||
+ | {{tp|p=32349165|t=2020. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?|pdf=|usr=}} | ||
+ | {{tp|p=32304612|t=2020. Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32135587|t=2020. 2019 novel coronavirus infection in a three-month-old baby |pdf=|usr=}} | ||
+ | {{tp|p=32234132|t=2020. First case of neonate with COVID-19 in China |pdf=|usr=}} | ||
+ | {{tp|p=32268709|t=2020. Attach importance to COVID-19 infection on maternal and infant outcomes |pdf=|usr=}} | ||
+ | {{tp|p=32145714|t=2020. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province |pdf=|usr=}} | ||
+ | |||
+ | |||
Zeile 261: | Zeile 338: | ||
*'''[[The morbid survivor]]''' | *'''[[The morbid survivor]]''' | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
+ | {{tp|p=32220181|t=2020. Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32286213|t=2020. Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man |pdf=|usr=}} | ||
+ | {{tp|p=32135586|t=2020. First case of severe childhood novel coronavirus pneumonia in China |pdf=|usr=}} | ||
+ | {{tp|p=32102141|t=2020. First case of 2019 novel coronavirus infection in children in Shanghai |pdf=|usr=}} | ||
+ | {{tp|p=32045966|t=2020. First case of severe childhood novel coronavirus pneumonia in China |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
{{tp|p=32270592|t=2020. Clinical characteristics of a case series of children with coronavirus disease 2019 |pdf=|usr=}} | {{tp|p=32270592|t=2020. Clinical characteristics of a case series of children with coronavirus disease 2019 |pdf=|usr=}} | ||
Zeile 268: | Zeile 354: | ||
{{tp|p=32175637|t=ä. Clinical features of deaths in the novel coronavirus epidemic in China |pdf=|usr=}} | {{tp|p=32175637|t=ä. Clinical features of deaths in the novel coronavirus epidemic in China |pdf=|usr=}} | ||
{{tp|p=32142398|t=2020. Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT |pdf=|usr=}} | {{tp|p=32142398|t=2020. Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT |pdf=|usr=}} | ||
+ | {{tp|p=32118389|t=2020. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Registries]]''' | *'''[[Registries]]''' | ||
Zeile 282: | Zeile 371: | ||
{{tp|p=32349053|t=ä. Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic |pdf=|usr=}} | {{tp|p=32349053|t=ä. Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic |pdf=|usr=}} | ||
{{tp|p=32369865|t=2020. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic |pdf=|usr=}} | {{tp|p=32369865|t=2020. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic |pdf=|usr=}} | ||
− | + | {{tp|p=32333712|t=2020. SARS-CoV-2 pandemic and the need for transplant-oriented trials |pdf=|usr=}} | |
Zeile 299: | Zeile 388: | ||
{{tp|p=32259313|t=2020. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 |pdf=|usr=}} | {{tp|p=32259313|t=2020. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 |pdf=|usr=}} | ||
{{tp|p=32281114|t=2020. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient |pdf=|usr=}} | {{tp|p=32281114|t=2020. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient |pdf=|usr=}} | ||
− | + | {{tp|p=32296012|t=2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia |pdf=|usr=}} | |
{{tp|p=32295694|t=2020. COVID-19 vaccination clinical trials should consider multiple doses of BCG |pdf=|usr=}} | {{tp|p=32295694|t=2020. COVID-19 vaccination clinical trials should consider multiple doses of BCG |pdf=|usr=}} | ||
{{tp|p=32326830|t=2020. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management |pdf=|usr=}} | {{tp|p=32326830|t=2020. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management |pdf=|usr=}} | ||
Zeile 321: | Zeile 410: | ||
{{tp|p=32360327|t=ä. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |pdf=|usr=}} | {{tp|p=32360327|t=ä. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |pdf=|usr=}} | ||
{{tp|p=32302280|t=2020. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department |pdf=|usr=}} | {{tp|p=32302280|t=2020. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department |pdf=|usr=}} | ||
+ | {{tp|p=32220178|t=2020. Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32374891|t=2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design |pdf=|usr=}} | ||
+ | {{tp|p=32374890|t=2020. COVID-19 convalescent plasma: phase 2 |pdf=|usr=}} | ||
+ | {{tp|p=32245869|t=2020. Possible treatment of Covid-19 with a therapeutic vaccine |pdf=|usr=}} | ||
+ | {{tp|p=32221001|t=2020. Possible method for the production of a Covid-19 vaccine |pdf=|usr=}} | ||
+ | {{tp|p=32324899|t=2020. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32319102|t=2020. Points to consider in the preparation and transfusion of COVID-19 convalescent plasma |pdf=|usr=}} | ||
+ | {{tp|p=32240545|t=2020. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?|pdf=|usr=}} | ||
+ | {{tp|p=32268018|t=2020. Analysis of medication characteristics of traditional Chinese medicine in treating coronavirus disease-19 based on data mining |pdf=|usr=}} | ||
+ | {{tp|p=32281335|t=2020. Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus |pdf=|usr=}} | ||
+ | {{tp|p=32281333|t=2020. Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32281332|t=2020. Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining |pdf=|usr=}} | ||
+ | {{tp|p=32281331|t=2020. Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32281330|t=2020. Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019 |pdf=|usr=}} | ||
+ | {{ttp|p=32281329|t=2020. Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway |pdf=|usr=}} | ||
+ | {{tp|p=32281328|t=2020. Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP |pdf=|usr=}} | ||
+ | {{tp|p=32281327|t=2020. Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
Zeile 367: | Zeile 490: | ||
{{tp|p=32237972|t=2020. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies |pdf=|usr=}} | {{tp|p=32237972|t=2020. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies |pdf=|usr=}} | ||
{{tp|p=32240543|t=ä. The impact of the SARS?CoV?2 outbreak on the safety and availability of blood transfusions in Italy |pdf=|usr=}} | {{tp|p=32240543|t=ä. The impact of the SARS?CoV?2 outbreak on the safety and availability of blood transfusions in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32220180|t=2020. Oral Health Management of Children during the Epidemic Period of Coronavirus Disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32310715|t=2020. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) |pdf=|usr=}} | ||
+ | {{tp|p=32096692|t=2020. Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32329654|t=2020. Telemedicine and e-Health Solutions for COVID-19: Patients Perspective |pdf=|usr=}} | ||
+ | {{tp|p=32329659|t=2020. Role of Telehealth in the Management of COVID-19: Lessons Learned from Previous SARS, MERS, and Ebola Outbreaks |pdf=|usr=}} | ||
+ | {{tp|p=32324109|t=2020. Telemedicine During The COVID-19 in Italy: A Missed Opportunity?|pdf=|usr=}} | ||
+ | {{tp|p=32198754|t=2020. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State |pdf=|usr=}} | ||
+ | {{tp|p=32280061|t=2020. COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?|pdf=|usr=}} | ||
+ | {{tp|p=32361996|t=2020. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission |pdf=|usr=}} | ||
+ | {{tp|p=32357275|t=2020. Strategies for prevention and control of the 2019 novel coronavirus disease in the department of kidney transplantation |pdf=|usr=}} | ||
+ | {{tp|p=32348586|t=2020. How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: A sound transplant protection strategy |pdf=|usr=}} | ||
+ | {{tp|p=32233049|t=2020. ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32267984|t=2020. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32267981|t=2020. ISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32255535|t=2020. ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound |pdf=|usr=}} | ||
+ | {{tp|p=32311760|t=2020. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment |pdf=|usr=}} | ||
+ | {{tp|p=32240537|t=2020. Post-donation COVID-19 identification in blood donors |pdf=|usr=}} | ||
+ | {{tp|p=32268712|t=2020. Perioperative management of cesarean section for pregnant women with suspected or confirmed COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32268711|t=2020. Systematic perinatal management of the pregnant women and neonates during the epidemic of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32268710|t=2020. Suggestions on delivery management of pregnant women with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32375428|t=2020. Protection suggestions on medical staff in obstetrics and gynecology in COVID-19-designated hospitals |pdf=|usr=}} | ||
+ | |||
Zeile 380: | Zeile 525: | ||
{{tp|p=32374894|t=2020. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19?|pdf=|usr=}} | {{tp|p=32374894|t=2020. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19?|pdf=|usr=}} | ||
{{tp|p=32273460|t=2020. Protecting older adults during social distancing |pdf=|usr=}} | {{tp|p=32273460|t=2020. Protecting older adults during social distancing |pdf=|usr=}} | ||
− | + | {{tp|p=32364037|t=2020. The reproductive health fall-out of a global pandemic |pdf=|usr=}} | |
Zeile 390: | Zeile 535: | ||
*'''[[Occupational medicine, workplace security and status hygienicus]]''' | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | ||
+ | {{tp|p=32299328|t=2020. Novel Coronavirus (COVID-19): What You Need to Know |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
{{tp|p=32377508|t=ä. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak |pdf=|usr=}} | {{tp|p=32377508|t=ä. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak |pdf=|usr=}} | ||
Zeile 410: | Zeile 558: | ||
{{tp|p=32273461|t=2020. Disinfection threatens aquatic ecosystems |pdf=|usr=}} | {{tp|p=32273461|t=2020. Disinfection threatens aquatic ecosystems |pdf=|usr=}} | ||
{{tp|p=32380152|t=ä. Potential infectious risk from the pets carrying SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32380152|t=ä. Potential infectious risk from the pets carrying SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32245870|t=2020. Can companion animals become infected with Covid-19?|pdf=|usr=}} | ||
+ | {{tp|p=32221002|t=2020. Can companion animals become infected with Covid-19?|pdf=|usr=}} | ||
+ | {{tp|p=32343036|t=2020. Cats under the shadow of the SARS-CoV-2 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32303108|t=2020. Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals |pdf=|usr=}} | ||
+ | {{tp|p=32303151|t=2020. Can the human coronavirus epidemic also spread through solid waste?|pdf=|usr=}} | ||
*'''[[Origin of Covid19]]''' | *'''[[Origin of Covid19]]''' | ||
+ | {{tp|p=32108071|t=2020. Where did SARS-CoV-2 come from?|pdf=|usr=}} | ||
+ | |||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
{{tp|p=32300018|t=2020. Demographic science aids in understanding the spread and fatality rates of COVID-19 |pdf=|usr=}} | {{tp|p=32300018|t=2020. Demographic science aids in understanding the spread and fatality rates of COVID-19 |pdf=|usr=}} | ||
Zeile 430: | Zeile 585: | ||
{{tp|p=32299940|t=2020. Protect Indigenous peoples from COVID-19 |pdf=|usr=}} | {{tp|p=32299940|t=2020. Protect Indigenous peoples from COVID-19 |pdf=|usr=}} | ||
{{tp|p=32273446|t=2020. Can prophylactic drugs keep fragile health systems running?|pdf=|usr=}} | {{tp|p=32273446|t=2020. Can prophylactic drugs keep fragile health systems running?|pdf=|usr=}} | ||
+ | {{tp|p=32205458|t=2020. Aggregated mobility data could help fight COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
Zeile 438: | Zeile 598: | ||
{{tp|p=32282658|t=2020. Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid Detection |pdf=|usr=}} | {{tp|p=32282658|t=2020. Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid Detection |pdf=|usr=}} | ||
{{tp|p=32356603|t=2020. Why the SARS-Cov-2 has prolonged spreading time in children?|pdf=|usr=}} | {{tp|p=32356603|t=2020. Why the SARS-Cov-2 has prolonged spreading time in children?|pdf=|usr=}} | ||
− | + | {{tp|p=32222122|t=2020. Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19) |pdf=|usr=}} | |
Zeile 487: | Zeile 647: | ||
{{tp|p=32054740|t=2020. Labs scramble to produce new coronavirus diagnostics |pdf=|usr=}} | {{tp|p=32054740|t=2020. Labs scramble to produce new coronavirus diagnostics |pdf=|usr=}} | ||
{{tp|p=32241928|t=2020. Vaccine designers take first shots at COVID-19 |pdf=|usr=}} | {{tp|p=32241928|t=2020. Vaccine designers take first shots at COVID-19 |pdf=|usr=}} | ||
− | + | {{tp|p=32299994|t=2020. Vets would not manage Covid-19 this way |pdf=|usr=}} | |
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
+ | {{tp|p=32186279|t=2020. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Research tools]]''' | *'''[[Research tools]]''' |
Version vom 2. Juni 2020, 17:42 Uhr
32352364 2020. Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base
32102777 2020. The 2019 novel coronavirus resource https://bigd.big.ac.cn/ncov
32286766 2020. Novel 2019 coronavirus SARS-CoV-2 (COVID-19): an overview for emergency clinicians
32179659 2020. COVID-19 in Children: Initial Characterization of the Pediatric Disease
32083985 2020. Coronavirus Disease 2019 (COVID-19): A Perspective from China
32301692 2020. What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic
32220177 2020. Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review
32306500 2020. Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak
32064795 2020. Diagnosis and treatment recommendation for pediatric coronavirus disease-19
32096367 2020. Management of corona virus disease-19 (COVID-19): the Zhejiang experience
32238232 2020. From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment
32186172 2020. Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia
32359076 2020. COVID-19: Use of the Clinical Frailty Scale for Critical Care Decisions
32215647 2020. Management of Critically Ill Adults With COVID-19
32159735 2020. Care for Critically Ill Patients With COVID-19
32242438 2020. Primary care management of the coronavirus (COVID-19)
32220179 2020. The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19
32352365 2020. Evidence Based Treatment of SARS-CoV2: A Narrative Review
32135584 2020. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)
32125126 2020. Management and clinical thinking of Coronavirus Disease 2019
32306656 2020. Clinical consideration and management of coronavirus disease 2019
32369222 2020. The management of coronavirus disease 2019 (COVID-19)
32249028 2020. The "helmet bundle" in COVID-19 patients undergoing non invasive ventilation
32268933 2020. Home PAP devices in COVID-19 infected patients
32074258 2020. Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation
32329799 2020. Management of COVID-19 Respiratory Distress
32376612 2020. Shared Ventilation in the Era of COVID-19: A Theoretical Consideration of the Dangers and Potential Solutions
32268019 2020. Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients
32273335 2020. COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life
32100976 2020. Airway management of COVID-19 patients with severe pneumonia
32306624 2020. Airway management of COVID-19 patients with severe pneumonia
32259916 2020. Experience of tracheotomy for critical patients with COVID-19: a case report
32292012 2020. Application of tracheotomy in the treatment of severe cases of COVID-19
32311181 2020. SARS-CoV-2: What can saliva tell us?
32364358 2020. A specifikus IgM- es IgG-antitesteket detektalo gyorstesztek erteke a SARS CoV-2 virusfertozes kimutatasaban (A COVID-19-pandemia orvosszakmai kerdesei)
32302058 2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures
32179122 2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
32380210 ä. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19
32302278 2020. The Appropriate Use of Testing for COVID-19
32223871 2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department
32317309 2020. Lung Ultrasound in Children With COVID-19
32142399 2020. FDG PET/CT of COVID-19
32228362 2020. 3D CT of Novel Coronavirus (COVID-19) Pneumonia
32339081 2020. AI Augmentation of Radiologist Performance in Distinguishing COVID-19 from Pneumonia of Other Etiology on Chest CT
32191588 2020. Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT
32243239 2020. Regarding "Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT"
32191587 2020. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study
32155105 2020. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT
32167853 2020. Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia?
32077789 2020. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection
32053470 2020. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
32073353 2020. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR
32101510 2020. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
32049601 2020. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing
32255413 2020. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society
32243238 2020. Chest CT Features of COVID-19 in Rome, Italy
32339082 2020. CO-RADS - A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation
32301647 2020. Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia
32301646 2020. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis
32049602 2020. Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia
32032497 2020. Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China
32031481 2020. CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia
32027573 2020. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
32017662 2020. Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist
32017661 2020. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
32013795 2020. 2019 Novel Coronavirus (2019-nCoV) Pneumonia
32003646 2020. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
32216717 2019. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients |
32374545 2020. Utilite du CT-scan thoracique pour le diagnostic et le triage des patients suspects de COVID-19
32351103 2020. The usual course of Thorax CT findings of Covid-19 infection and When should control Thorax CT scan?
32317269 2020. Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT
32352366 2020. How to Deal with COVID-19 Pandemic: A Radiologic Approach
32286216 2020. Diagnostic imaging findings in COVID-19
32294796 2020. Nicht-invasive Beurteilung von pulmonalen Lasionen bei Patienten mit Coronavirus-Erkrankung (COVID-19) durch Ultraschall direkt am Krankenbett
32294795 2020. ... Ultraschall in der Ara der COVID-19-Pandemie ...
32207208 2020. How to perform lung ultrasound in pregnant women with suspected COVID-19
32337795 2020. Clinical role of lung ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in pregnant women
32249471 2020. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19
32207591 2020. CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)
32096366 2020. Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)
32061200 2020. Analysis of CT features of 15 Children with 2019 novel coronavirus infection
32234131 2020. Analysis of CT features of 15 children with 2019 novel coronavirus infection
32238585 2020. Isolation and Full-Length Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy
32238584 2020. Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2
32365353 2020. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
32216114 ä. Structural and biochemical characterization of SADS?CoV papain?like protease 2
32304108 2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2
32225176 2020. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
32225175 2020. Structural basis of receptor recognition by SARS-CoV-2
32376634 2020. Cell entry mechanisms of SARS-CoV-2 |
32329276 2020. Spike protein in the detection and treatment of novel coronavirus
32298055 2020. Replication and transmission mechanisms of highly pathogenic human coronaviruses
32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |
32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32343429 2020. Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis
32192578 2020. COVID-19: consider cytokine storm syndromes and immunosuppression
32303591 2020. Cytokine release syndrome in severe COVID-19
32273618 2020. How does COVID-19 kill? Uncertainty is hampering doctors ability to choose treatments
32371892 2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms |
32339089 2020. Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis
32172546 2020. A pathological report of three COVID-19 cases by minimal invasive autopsies
32171194 2020. Pathological changes with novel coronavirus infection in lung cancer surgical specimen
32153166 2020. Provisional guidelines on autopsy practice for deaths associated with COVID-19
32268662 2020. Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy
32157847 2020. How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome
32084674 2020. Detection of 2019-nCoV in the pathological paraffin embedded tissue
32340089 2020. Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies
32114744 2020. Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases
32380511 2020. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
32369435 2020. Canine Respiratory Coronavirus: A Naturally Occurring Model of COVID-19?
32319148 2020. COVID-19: searching for clues among other respiratory viruses
32237148 2020. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center
32265517 2020. SARS-CoV-2 detection in patients with influenza-like illness
32287052 2020. Febrile Infant: COVID-19 in Addition to the Usual Suspects
32245885 2020. Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? |
32358120 2020. How related is SARS-CoV-2 to other coronaviruses?
15631713 2004. A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children
32198915 2020. When COVID-19 encounters interstitial lung disease: challenges and management
32339350 2020. COVID-19 associated pulmonary aspergillosis
32379193 2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION
32287051 2020. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)
32376725 2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children
32238260 2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas
32367765 2020. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
32367749 2020. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia
32376225 ä. Pulmonary embolism in COVID-19 When nothing is what it seems
32324101 2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
32324103 2020. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography
32324102 2020. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels
32324099 2020. Pulmonary, Cerebral, and Renal Thromboembolic Disease Associated with COVID-19 Infection
32374544 2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives
32378030 ä. COVID-19-Related Stroke
32279286 2020. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
32349133 2020. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge
32349132 2020. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
32316065 2020. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
32316063 2020. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
32374920 2020. Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
32366611 2020. Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia
32380269 ä. The COVID-19 pandemic: consideration for brain infection
32379311 ä. Letter: Anosmia in COVID-19: Severe Acute Respiratory Syndrome Coronavirus 2 Through the Nasoliary Epithelium and a Possible Spreading Way to the Central Nervous System?A Purpose to Study
32358218 2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
32345728 2020. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19
32327489 2020. Neurologic manifestations in an infant with COVID-19
32303650 2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19
32333489 2020. Is gustatory impairment the first report of an oral manifestation in COVID-19?
32369434 2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?
32369429 2020. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis
32366195 2020. Anosmia and the Need for COVID-19 Screening during the Pandemic
32366161 2020. Olfactory Dysfunction in COVID-19
32366160 2020. Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance
32340555 2020. COVID-19 Anosmia Reporting Tool: Initial Findings
32366595 2020. Acute anosmia from COVID-19 infection
32228363 2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
32338254 2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss
32319971 2020. Anosmia as a prominent symptom of COVID-19 infection
32240279 2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?
32277751 2020. Presentation of new onset anosmia during the COVID-19 pandemic
32320129 2020. Explanation for COVID-19 infection neurological damage and reactivations
32220634 2020. Sars-Cov-2: Underestimated damage to nervous system
32369674 2020. Oral vesiculobullous lesions associated with SARS-CoV-2 infection
32374033 2020. Chilblains-like lesions in children following suspected Covid-19 infection
32315079 2020. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?
32367837 2020. Gastrointestinal and liver manifestations of COVID-19
32369476 2020. Sintomas digestivos en la enfermedad por coronavirus 2019 (COVID-19)
32153170 2020. Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region
32270660 2020. Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area
32077660 2020. Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study
32077659 2020. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia
32075364 2020. Novel coronavirus pneumonia-related liver injury: etiological analysis and treatment strategy
32249664 2020. Focus on the Crosstalk Between COVID-19 and Urogenital Systems
32365180 ä. Potential influence of COVID-19/ACE2 on the female reproductive system
32340507 2020. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis
32348049 2020. Vue sur le COVID-19 depuis la nephrologie
32281287 2020. Risk of COVID?19 for patients with obesity
32237212 ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out
32332320 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia
32250049 ä. COVID?19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings
32365269 2020. Obesity and severe COVID-19 disease: a strong association
32365275 2020. Obesity accompanying COVID-19: the role of epicardial fat
32352637 2020. Association of Obesity with Disease Severity among Patients with COVID-19
32339391 2020. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32314871 2020. Targeting the Adipose Tissue in COVID-19
32314868 2020. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
32314861 2020. Obesity is Associated with Severe Forms of COVID-19
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
32366612 2020. Early Neonatal SARS-CoV-2 Infection Manifesting With Hypoxemia Requiring Respiratory Support
32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children
32339304 2020. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression
32234837 2020. COVID-19 and non-communicable diseases
32304114 2020. Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission
32377638 2020. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
32319449 2020. A pregnant woman and the SARS-CoV-2 infection: how are barriers easily crossed?
32374541 2020. Diabete et infection a COVID-19
32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides
32301198 ä. Case report: A kidney transplant patient with mild COVID?19
32160345 ä. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
32302282 2020. Sex- and Gender-specific Observations and Implications for COVID-19
32364677 2020. COVID-19 pneumonia in kidney transplant recipients-Where we are?
32279418 2020. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19)
32357273 2020. A catabolic state in a kidney transplant recipient with COVID-19
32180292 2020. Coronavirus in pregnancy and delivery: rapid review |
32266753 2020. Intrauterine vertical transmission of SARS-CoV-2: what we know so far
32349165 2020. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
32304612 2020. Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
32135587 2020. 2019 novel coronavirus infection in a three-month-old baby
32234132 2020. First case of neonate with COVID-19 in China
32268709 2020. Attach importance to COVID-19 infection on maternal and infant outcomes
32145714 2020. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province
32220181 2020. Clinical Study and CT Findings of a Familial Cluster of Pneumonia with Coronavirus Disease 2019 (COVID-19)
32286213 2020. Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man
32135586 2020. First case of severe childhood novel coronavirus pneumonia in China
32102141 2020. First case of 2019 novel coronavirus infection in children in Shanghai
32045966 2020. First case of severe childhood novel coronavirus pneumonia in China
32270592 2020. Clinical characteristics of a case series of children with coronavirus disease 2019
32259403 2020. Novel coronavirus infection in children outside of Wuhan, China
32244248 2020. COVID-19 in children and altered inflammatory responses
32374856 ä. Characteristics of Doctors? Fatality due to COVID-19 in Western Europe and Asia-Pacific countries
32175637 ä. Clinical features of deaths in the novel coronavirus epidemic in China
32142398 2020. Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT
32118389 2020. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China
32377641 ä. Initial data from the COVID-19 Global Rheumatology Alliance provider registries
32377642 ä. Initial data from the COVID-19 Global Rheumatology Alliance provider registries ? Authors reply
32374851 ä. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance |
32379296 2020. Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19)
32341581 2020. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials
32179860 2020. Don t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees
32349053 ä. Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic
32369865 2020. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
32333712 2020. SARS-CoV-2 pandemic and the need for transplant-oriented trials
32377399 2020. COVID-19 vaccines: breaking record times to first-in-human trials
32297843 2020. Oligonucleotides and the COVID-19 Pandemic: A Perspective
32380200 ä. In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2
32275178 2020. Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
32216577 2020. Artificial intelligence and machine learning to fight COVID-19
32380051 ä. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
32352615 2020. Povidone-iodine gargle as a prophylactic intervention to interrupt the transmission of SARS-CoV-2
32209313 2020. New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
32285489 2020. Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity
32267566 2020. Therapeutic Potential for Tetracyclines in the Treatment of COVID-19
32267560 2020. Considerations for Statin Therapy in Patients with COVID-19
32259313 2020. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
32281114 2020. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient
32296012 2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
32295694 2020. COVID-19 vaccination clinical trials should consider multiple doses of BCG
32326830 2020. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management
32330404 2020. Can Transdermal Photobiomodulation Help Us at the Time of COVID-19?
32352594 2020. Phytotherapic compounds against coronaviruses: Possible streams for future research
32347602 2020. Should we try the antiinflammatory natural product, celastrol, for COVID-19?
32350134 2020. Effective treatment of severe COVID-19 patients with tocilizumab
32365207 ä. Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
32314850 2020. Melatonin: Roles in influenza, Covid?19, and other viral infections
32374874 ä. COVID-19: an unexpected indication for anti-rheumatic therapies?
32376603 ä. Development of an inactivated vaccine candidate for SARS-CoV-2
32352871 2020. A Radiation Mitigator as a Potential Treatment for COVID-19
32273254 2020. Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic
32167254 2020. Epidemie de coronavirus et polemique sur la chloroquine
32270942 2020. Covid-19, dans les brouillards francais de l'hydroxychloroquine
32301315 2020. Covid-19, dans les brouillards de l'hydroxychloroquine (2)
32301312 2020. Vaccins anti-covid-19 : les recherches de johnson & johnson, sanofi et pasteur
32355008 2020. COVID-19 shot protects monkeys
32292113 2020. Stem Cell?Based Therapy for Coronavirus Disease 2019
32272857 2020. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks
32360327 ä. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence
32302280 2020. Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
32220178 2020. Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019
32374891 2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design
32374890 2020. COVID-19 convalescent plasma: phase 2
32245869 2020. Possible treatment of Covid-19 with a therapeutic vaccine
32221001 2020. Possible method for the production of a Covid-19 vaccine
32324899 2020. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy
32319102 2020. Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
32240545 2020. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
32268018 2020. Analysis of medication characteristics of traditional Chinese medicine in treating coronavirus disease-19 based on data mining
32281335 2020. Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus
32281333 2020. Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019
32281332 2020. Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining
32281331 2020. Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19
32281330 2020. Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019
32281329 2020. Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway |
32281328 2020. Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP
32281327 2020. Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking
32367576 2020. Saliva is a non-negligible factor in the spread of COVID-19
32304466 2020. FECAL-ORAL TRANSMISSION OF SARS-COV-2 IN CHILDREN: IS IT TIME TO CHANGE OUR APPROACH?
32273447 2020. NAS letter suggests normal breathing can expel coronavirus
32215590 2020. Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19
32340022 2020. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
32356927 2020. Consideration of the Aerosol Transmission for COVID-19 and Public Health
32320083 2020. Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports
32291807 2020. The importance of the minimum dosage necessary for UVC decontamination of N95 respirators during the COVID-19 pandemic
32336079 2020. Medical mask or N95 respirator: When and how to use?
32372076 ä. SARS-CoV-2 human disinfection chambers: a critical analysis
32295880 2020. Inner Workings: Molecular biologists offer ?wartime service? in the effort to test for COVID-19
32246121 2020. Safely conducting essential research in the face of COVID-19
32380501 2020. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
32365049 2020. Tracheotomia az uj tipusu koronavirus okozta jarvany idejen(A COVID-19-pandemia orvosszakmai kerdesei)
32286909 2020. COVID-19 Pandemic: What Every Otolaryngologist-Head and Neck Surgeon Needs to Know for Safe Airway Management
32380508 2020. Neonatal emergency transport system during COVID-19 pandemic in the Veneto Region: proposal for standard operating procedures
32312176 2020. Peritoneal Dialysis in the time of COVID-19
32364280 2020. The Role of Scientific Publishing in the SARS-CoV-2 Pandemic
32371404 2020. Medical education during the COVID-19 pandemic: perspectives from UK trainees
32312755 2020. Impact of cancelling foundation year rotations due to the covid-19 outbreak in the UK
32277490 2020. SARS-CoV2 (COVID-19) infection: is fetal surgery in times of national disasters reasonable?
32376131 ä. LA PSIQUIATR�A EN LAS SECUELAS DE COVID-19
32125934 2020. Helping the Radiologist: The Role of Scientific Journals to Help Prevent the Spread of COVID-19
32324100 2020. Imaging Publications in the COVID-19 Pandemic: Applying New Research Results to Clinical Practice
32216248 2020. Prevencion y control de la infeccion por coronavirus SARS-CoV-2 (Covid-19) en unidades de hemodialisis
32193300 2020. Coronavirus disruptions reverberate through research
32237972 2020. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies
32240543 ä. The impact of the SARS?CoV?2 outbreak on the safety and availability of blood transfusions in Italy
32220180 2020. Oral Health Management of Children during the Epidemic Period of Coronavirus Disease 2019
32310715 2020. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
32096692 2020. Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19
32329654 2020. Telemedicine and e-Health Solutions for COVID-19: Patients Perspective
32329659 2020. Role of Telehealth in the Management of COVID-19: Lessons Learned from Previous SARS, MERS, and Ebola Outbreaks
32324109 2020. Telemedicine During The COVID-19 in Italy: A Missed Opportunity?
32198754 2020. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State
32280061 2020. COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
32361996 2020. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
32357275 2020. Strategies for prevention and control of the 2019 novel coronavirus disease in the department of kidney transplantation
32348586 2020. How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: A sound transplant protection strategy
32233049 2020. ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID-19
32267984 2020. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2
32267981 2020. ISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2
32255535 2020. ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound
32311760 2020. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
32240537 2020. Post-donation COVID-19 identification in blood donors
32268712 2020. Perioperative management of cesarean section for pregnant women with suspected or confirmed COVID-19
32268711 2020. Systematic perinatal management of the pregnant women and neonates during the epidemic of COVID-19
32268710 2020. Suggestions on delivery management of pregnant women with COVID-19
32375428 2020. Protection suggestions on medical staff in obstetrics and gynecology in COVID-19-designated hospitals
32314806 2020. Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy
32340050 2020. Erfahrungen und Belastungserleben niedergelassener Neurologen und Psychiater wahrend der COVID-19-Pandemie
32317306 2020. Increased Risk for Family Violence During the COVID-19 Pandemic
32380343 ä. Potential Threats of COVID-19 On Quarantined Families
32374894 2020. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19?
32273460 2020. Protecting older adults during social distancing
32364037 2020. The reproductive health fall-out of a global pandemic
32359403 ä. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
32343497 ä. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy
32299328 2020. Novel Coronavirus (COVID-19): What You Need to Know
32377508 ä. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak
32273610 2020. If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future
32269308 2020. COVID-19 brings drug development to a halt
32284558 2020. How COVID-19 could ruin weather forecasts and climate records
32375016 2020. Workforce Survival: Tracking Potential COVID-19 Exposure Amid Socioeconomic Activities Using Automatic Log-Keeping Apps
32273444 2020. Pandemic brings mass vaccinations to a halt
32380370 ä. COVID-19 pandemic: Impacts on the air quality during the partial lockdown in S�o Paulo state, Brazil
32298883 2020. Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia
32217719 2020. COVID-19 drives new threat to bats in China
32273461 2020. Disinfection threatens aquatic ecosystems
32380152 ä. Potential infectious risk from the pets carrying SARS-CoV-2
32245870 2020. Can companion animals become infected with Covid-19?
32221002 2020. Can companion animals become infected with Covid-19?
32343036 2020. Cats under the shadow of the SARS-CoV-2 pandemic
32303108 2020. Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals
32303151 2020. Can the human coronavirus epidemic also spread through solid waste?
32108071 2020. Where did SARS-CoV-2 come from?
32300018 2020. Demographic science aids in understanding the spread and fatality rates of COVID-19
32218546 2020. What the cruise-ship outbreaks reveal about COVID-19
32345687 2020. Sheltering in Place in a Xenophobic Climate: COVID-19 and Children in Immigrant Families
32179660 2020. Epidemiology of COVID-19 Among Children in China
32356510 2020. Covid-19 and public health
32353901 2020. Rationale for universal face masks in public against COVID-19
32353723 2020. Early forecasting of the potential risk zones of COVID-19 in China s megacities
32304371 2020. Alfabetizacion en salud publica ante la emergencia de la pandemia por Covid-19
32356896 2020. The COVID-19 (Coronavirus) pandemic: consequences for occupational health
32315842 2020. The international imperative to rapidly and inexpensively monitor community-wide Covid-19 infection status and trends
32332062 2020. Modeling infectious disease dynamics
32139521 2020. Can China s COVID-19 strategy work elsewhere?
32165563 2020. Airport screening is largely futile, research shows
32165562 2020. Genome analyses help track coronavirus moves
32299940 2020. Protect Indigenous peoples from COVID-19
32273446 2020. Can prophylactic drugs keep fragile health systems running?
32205458 2020. Aggregated mobility data could help fight COVID-19
32296168 2020. Temporal dynamics in viral shedding and transmissibility of COVID-19
32243729 ä. The isolation period should be longer: Lesson from a child infected with SARS?CoV?2 in Chongqing, China
32379191 2020. Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan
32282658 2020. Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid Detection
32356603 2020. Why the SARS-Cov-2 has prolonged spreading time in children?
32222122 2020. Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)
32352911 2020. COVID-19 reveals weak health systems by design: Why we must re-make global health in this historic moment
32273583 2020. When COVID-19 meets centralized, personalized power
32217720 2020. Travel restrictions violate international law
32371962 2020. Going viral: how to boost the spread of coronavirus science on social media
32377576 2020. Chatbots in the fight against the COVID-19 pandemic
32231320 2020. Blocking information on COVID-19 can fuel the spread of misinformation
32379194 2020. Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan
32321859 2020. Twitter as a powerful tool for communication between pain physicians during COVID-19 pandemic
32198292 2020. Misguided drug advice for COVID-19
32317499 2020. A tribute to frontline corona warriors--Doctors who sacrificed their life while saving patients during the ongoing COVID-19 pandemic
32238428 2020. Dr Li Wenliang and the Time of COVID-19
32303602 2020. Letter to the Editor: Who was the first doctor to report the Covid-19 outbreak in Wuhan, China?
32310289 2020. Health Care Heroes of the COVID-19 Pandemic
32049461 2020. Coronavirus : Dr Li Wenliang, lanceur d'alerte, heros et martyr
32374357 2020. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports")
32380041 2020. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
32364048 2020. The BMA COVID-19 ethical guidance: a legal analysis
32349615 2020. COVID-19: A personal perspective
32371403 2020. A personal historical perspective of HIV
32355024 2020. Call for transparency of COVID-19 models
32217705 2020. Race to find COVID-19 treatments accelerates
32213646 2020. COVID-19 needs a big science approach
32054740 2020. Labs scramble to produce new coronavirus diagnostics
32241928 2020. Vaccine designers take first shots at COVID-19
32299994 2020. Vets would not manage Covid-19 this way
32186279 2020. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak
32339250 2020. A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019
32275081 2020. Evaluate severe acute respiratory syndrome coronavirus 2 infectivity by pseudoviral particles
32365353 2020. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
32349121 2020. Massively multiplexed nucleic acid detection with Cas13
32108094 2020. Preprints bring firehose of outbreak data
- from the ads
- [lunanano.com rna purfication]
- [sierramolecular.com rna safe sample collection]